| 104234-0 | Atomoxetine (Urine, confirmatory method) | DRUG/TOX |
| 104235-7 | Dibutylone (Urine, confirmatory method) | DRUG/TOX |
| 104236-5 | 3-fluorophenmetrazine (Urine, confirmatory method) | DRUG/TOX |
| 104237-3 | Zopiclone (Urine, confirmatory method) | DRUG/TOX |
| 104238-1 | Chronic and low grade B cell lymphoid neoplasm multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 104239-9 | B cell non hodgkin Lymphoma multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 10424-0 | Transfuse erythrocytes | BLDBK |
| 104240-7 | Histiocytic neoplasm multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 104241-5 | Plasma cell myeloma multigene analysis (Bone Marrow, molecular genetics method) | MOLPATH |
| 104242-3 | T cell lymphoma multigene analysis or Tissue (Blood, molecular genetics method) | MOLPATH |
| 104243-1 | Left ventricular Ejection fraction - lower limit (us.2d.a3c+estimated) | CARD.US |
| 104244-9 | Left ventricular Ejection fraction - lower limit (us.2d.a4c+estimated) | CARD.US |
| 104245-6 | Left ventricular Ejection fraction - lower limit (us.3d.a2c+estimated) | CARD.US |
| 104246-4 | Left ventricular Ejection fraction - lower limit (us.3d.a3c+estimated) | CARD.US |
| 104247-2 | Left ventricular Ejection fraction - lower limit (us.3d.a4c+estimated) | CARD.US |
| 104248-0 | Pepsinogen I/Pepsinogen II | CHEM |
| 104249-8 | Platelet aggregation (Blood, adp induced atp secretion 2 umol/l) | COAG |
| 10425-7 | Transfuse Rh immune globulin | BLDBK |
| 104250-6 | Platelet aggregation in Platelet rich plasma (collagen induced 2 ug/ml) | COAG |
| 104251-4 | Left ventricular Ejection fraction (us.2d.a2c+estimated) | CARD.US |
| 104252-2 | Left ventricular Ejection fraction (us.2d.a3c+estimated) | CARD.US |
| 104253-0 | Left ventricular Ejection fraction (us.2d.a4c estimated) | CARD.US |
| 104254-8 | Left ventricular Ejection fraction (us.3d.a2c+estimated) | CARD.US |
| 104255-5 | Left ventricular Ejection fraction (us.3d.a3c+estimated) | CARD.US |
| 104256-3 | Left ventricular Ejection fraction (us.3d.a4c+estimated) | CARD.US |
| 104258-9 | Left ventricular Ejection fraction - lower limit (us.2d.a2c+estimated) | CARD.US |
| 104259-7 | Fibroblast growth factor 23 (Tissue, qualitative, fish) | CHEM |
| 10426-5 | Transfuse whole blood | BLDBK |
| 104260-5 | Hepatitis A virus cellular receptor 1 (Urine, calculation) | CELLMARK |
| 104261-3 | Eosinophil derived neurotoxin (Serum, immunoassay) | HEM/BC |
| 104262-1 | Diagnostic peripheral vascular disease study Heart | CARD.PROC |
| 104263-9 | Galactosylceramidase (lc/ms/ms) | CHEM |
| 104264-7 | Galactosylceramidase (CSF, lc/ms/ms) | CHEM |
| 104265-4 | Ethanol cutoff in Exhaled gas | DRUG/TOX |
| 104266-2 | Immunoglobulins and heavy-light chain panel - Serum or Plasma | PANEL.CHEM |
| 104267-0 | Protein.glycosylated (qualitative) | CHEM |
| 104268-8 | UBA1 gene mutation in Specimen (molecular genetics method) | MOLPATH.MUT |
| 104269-6 | V gene rearrangement in Specimen (molecular genetics method nominal) | MOLPATH.REARRANGE |
| 10427-3 | Transfuse whole blood autologous | BLDBK |
| 104270-4 | J gene rearrangement in Specimen (molecular genetics method nominal) | MOLPATH.REARRANGE |
| 104271-2 | Primer set in Specimen (molecular genetics method) | MOLPATH |
| 104272-0 | IgH and IgK gene rearrangement status in Specimen (molecular genetics method nominal) | MOLPATH.REARRANGE |
| 104273-8 | Clonal cells rearrangements/Cells counted in Specimen (molecular genetics method) | MOLPATH.REARRANGE |
| 104274-6 | Abnormal clonal sequences in Specimen (molecular genetics method nominal) | MOLPATH |
| 104275-3 | Hematopoietic progenitor cells/Cells.total (automated count) | HEM/BC |
| 104276-1 | ALK gene mutations tested for or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 104277-9 | MET gene mutations tested for or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 104278-7 | BRAF gene mutations tested for or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 104279-5 | ERBB2 gene mutations tested for or Tissue (Blood, molecular genetics method nominal) | MOLPATH.MUT |
| 10428-1 | Varicella zoster virus immune globulin given | BLDBK |